Key facts
- This page summarizes Robert J. Ciaruffoli's Form 3 filing for Medicus Pharma Ltd. (MDCX).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 31 Dec 2024, 16:06.
Robert J. Ciaruffoli - 31 Dec 2024 Form 3 Insider Report for Medicus Pharma Ltd. (MDCX)
- Reporting relationship
- Director
- Issuer ticker
- MDCX
- Reported as of
- 31 Dec 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 31 Dec 2024, 16:06:39 UTC
- Next SEC filing
- 24 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ James Quinlan, as Attorney-in-Fact, for Robert J. Ciaruffoli
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Robert J. Ciaruffoli filed Form 3 for Medicus Pharma Ltd. (MDCX) on 31 Dec 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
This filing has been restated.
Open the amended filing.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MDCX
holding
Common Shares, no par value ("Common Shares")
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 12,500
- Date
- 31 Dec 2024
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MDCX
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 31 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 25,000
- Exercise price
- $0.8100
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The option has vested and is exercisable as of the date hereof.
Footnote F2
Represents an exercise price of $1.16 Canadian dollars, converted to U.S. dollars at the daily average exchange rate of $1.00 to CAD$1.4379 reported by the Bank of Canada on December 30, 2024.
SEC remarks
Exhibit List - Exhibit 24.1 - Power of Attorney